September 26, 2026
Every successful investor knows a painful truth: knowing when to sell is often more critical than knowing what to buy.
While financial media overwhelmingly focuses on buying opportunities, our research consistently identifies companies facing significant headwinds that merit serious consideration for selling. These aren’t just stocks underperforming the market; they’re businesses confronting structural challenges, deteriorating fundamentals, or carrying valuations disconnected from financial reality.
What you won’t find here: reactionary calls based on short-term price movements or headline volatility. Each company on this list has been thoroughly analyzed across multiple metrics that historically precede substantial declines.
Smart investors understand that portfolio management requires both addition and subtraction. Sometimes the best investment decision is to redeploy capital away from troubling positions before problems fully materialize in the share price.
This week’s watchlist highlights stocks showing critical weaknesses that demand immediate attention:
Turning Point Brands (TPB)
Turning Point Brands demonstrates how leadership instability and reduced profitability expectations can compound to erode investor confidence within a single trading week, with shares declining nearly 12% week-to-date following a surprise CEO resignation combined with unwelcome guidance revisions and a significant analyst price target cut. The tobacco company opened the week by announcing that CEO Graham Purdy would step down due to unspecified “personal circumstances that require his immediate attention,” with executive chairman David Glazek set to assume the role effective October 1—a transition timeline that provides minimal advance notice for a leadership change at a public company and offers no substantive explanation for the abrupt departure, leaving investors to speculate about whether deeper organizational issues might underlie the vague circumstances cited.
Compounding this leadership uncertainty, Turning Point simultaneously revised its full-year 2026 guidance in ways that, while maintaining oral tobacco net sales expectations at $260 million to $270 million, lowered the top end of adjusted EBITDA guidance to a range of $70 million to $80 million from the previous $70 million to $90 million range—effectively narrowing the guidance band entirely from the upside, signaling that management now views the more optimistic profitability scenarios as unachievable. This guidance reduction arriving simultaneously with the CEO transition raises questions about whether the departing executive’s exit relates to the company’s inability to meet previously communicated profitability targets, even though management has not drawn this connection explicitly. The following day, Oppenheimer analyst Ian Zaffino delivered a further blow by slashing his price target to $90 per share from $130 while maintaining an outperform rating, representing a substantial 31% reduction in expected value even as the analyst retained his fundamentally bullish stance on the stock.
Trading at around $60 per share with a market capitalization of approximately $1.2 billion, Turning Point Brands carries a valuation that must now account for both leadership transition risk during a critical period and reduced profitability expectations that management itself has acknowledged through narrowed EBITDA guidance. The stock’s 52-week range of $58.57 to $146.90 reveals shares trading at the very bottom of this range, reflecting the severity of the recent selloff and broader investor concern about a tobacco company navigating simultaneous leadership uncertainty and deteriorating profit visibility. For consumer staples investors, Turning Point Brands represents a company facing the classic warning combination of unexpected executive departure and downward guidance revision occurring in immediate succession, with the timing correlation between these events—even absent explicit management acknowledgment of a connection—creating legitimate concern about whether the incoming leadership team inherits a business facing more significant operational challenges than previously disclosed.
Paychex (PAYX)
Paychex exemplifies how earnings quality deterioration can undermine investor confidence even when headline results technically beat expectations, with shares falling 6.7% despite the payroll and HR services company meeting revenue targets and beating on adjusted earnings in its fiscal first-quarter 2027 report. The company grew revenue 6% year-over-year to hit analyst expectations precisely, while adjusted earnings of $1.34 per share topped the $1.32 consensus estimate, and both operating income and GAAP net income grew at double the revenue growth rate at 14%—metrics that on the surface suggest healthy operating leverage and margin expansion. However, closer examination reveals concerning earnings quality issues, with actual GAAP earnings per share coming in meaningfully lower at $1.21 compared to the headline adjusted figure of $1.34, while free cash flow of just $357.4 million represented only 87% of reported net income and declined significantly from the prior-year period.
This cascading deterioration—where adjusted earnings exceed GAAP earnings, which in turn exceed free cash flow generation—represents exactly the pattern that sophisticated investors watch for as an early warning sign of deteriorating earnings quality, suggesting that reported profitability increasingly depends on non-cash adjustments and accounting treatments rather than genuine cash generation capability. While Paychex maintained the bulk of its prior fiscal 2027 guidance, including continued 5-6% revenue growth and adjusted operating margins improving to 44% from 42% in Q1, management’s guidance for only 7-9% improvement in adjusted earnings per share raises valuation concerns given the stock’s current pricing. With shares trading at 23 times earnings while the company grows earnings at less than 10% annually based on guidance, the valuation multiple appears stretched relative to underlying growth rates, particularly when the free cash flow shortfall relative to reported earnings suggests genuine cash-based profitability may be growing even more slowly than the already modest guided earnings growth rate.
Trading at around $102 per share with a market capitalization of approximately $36 billion, Paychex carries a valuation that assumes premium multiple justification despite growth rates that appear pedestrian relative to the 23 times earnings multiple investors currently pay, a disconnect that becomes more troubling given the earnings quality concerns evident in the cascading gap between adjusted earnings, GAAP earnings, and free cash flow. The stock’s 52-week range of $85.45 to $130.32 illustrates substantial volatility as investors reassess appropriate valuation levels for a company whose reported profitability metrics increasingly diverge from underlying cash generation. For business services investors, Paychex represents a case where surface-level earnings beats mask underlying quality deterioration, with the significant gaps between adjusted earnings, GAAP earnings, and free cash flow suggesting that reported growth rates may overstate the company’s genuine cash-generating capability, creating valuation risk for a stock still commanding a premium multiple despite single-digit growth guidance.
Manchester United (MANU)
Manchester United demonstrates how sports franchise ownership can deliver disappointing financial returns even amid operational and competitive improvements, with shares slipping 3% following fiscal 2026 full-year results that revealed a concerning combination of minimal revenue growth, a swing to operating profitability, yet a persistent net loss on the bottom line. The football club reported record annual revenue of £677.6 million ($899 million), representing just 1.7% growth from the prior year—a remarkably modest increase for a organization of Manchester United’s global brand recognition and commercial reach—while operating earnings improved from a loss in the prior year to a £22.6 million ($30 million) profit, demonstrating some operational progress. Despite this operating improvement, the club still reported a net loss of £43 million ($57 million), highlighting the substantial gap between operational performance and bottom-line profitability that continues to challenge the organization’s overall financial health.
Management attributed the underwhelming results primarily to the men’s team’s absence from UEFA Champions League competition during the fiscal year, with the financial impact of missing this lucrative tournament apparently overwhelming positive developments including the women’s team reaching the Champions League quarter-finals for the first time and placing fourth in the Women’s Super League. While the men’s team’s third-place Premier League finish secured Champions League qualification for the 2026/27 season—theoretically positioning the club for improved financial results ahead—the forward guidance provided by management actually undercuts this optimistic narrative, with fiscal 2027 revenue guidance of £740 million to £760 million (up to 12% improvement) paired with adjusted EBITDA guidance of £205 million to £225 million that, at the midpoint, implies the club may generate less operating profitability next year despite meaningfully higher revenue. Compounding this concerning guidance dynamic, management provided no net earnings guidance whatsoever, leaving investors unable to assess whether the persistent net losses that have plagued the club’s bottom line might finally reverse even as Champions League qualification should theoretically boost overall financial performance.
Trading at around $21 per share with a market capitalization of approximately $3.6 billion and a striking negative 112.53% gross margin, Manchester United carries a valuation that must contend with a business structure where returning to elite European competition—typically viewed as a major financial catalyst for football clubs—still translates into guidance implying flat-to-declining operating profitability despite substantially higher projected revenue. The stock’s 52-week range of $14.85 to $24.45 reflects the speculative and sentiment-driven nature of sports franchise equity investing, where fan enthusiasm and competitive results often drive share price movements disconnected from the fundamental financial metrics that typically govern equity valuations. For investors considering Manchester United, the club represents a cautionary example of how emotional attachment to a beloved sports franchise can obscure the reality that the underlying business continues generating net losses even during periods of competitive and revenue improvement, with management’s own forward guidance suggesting that Champions League qualification alone will not resolve the structural profitability challenges facing the organization.
